title: Subcellular tissue proteomics of hepatocellular carcinoma for molecular signature discovery.
abstract: Hepatocellular carcinoma (HCC) is one of the leading causes of mortality from solid organ malignancy worldwide. Because of the complexity of proteins within liver cells and tissues, the discovery of therapeutic targets of HCC has been difficult. To investigate strategies for decreasing the complexity of tissue samples for detecting meaningful protein mediators of HCC, we employed subcellular fractionation combined with 1D-gel electrophoresis and liquid chromatography-tandem mass spectrometry analysis. Moreover, we utilized a statistical method, namely, the Power Law Global Error Model (PLGEM), to distinguish differentially expressed proteins in a duplicate proteomic data set. Mass spectrometric analysis identified 3045 proteins in nontumor and HCC from cytosolic, membrane, nuclear, and cytoskeletal fractions. The final lists of highly differentiated proteins from the targeted fractions were searched for potentially translocated proteins in HCC from soluble compartments to the nuclear or cytoskeletal compartments. This analysis refined our targets of interest to include 21 potential targets of HCC from these fractions. Furthermore, we validated the potential molecular targets of HCC, MATR3, LETM1, ILF2, and IQGAP2 by Western blotting, immunohistochemisty, and immunofluorescent microscopy. Here we demonstrate an efficient strategy of subcellular tissue proteomics toward molecular target discovery of one of the most complicated human disease, HCC.
authors.affiliation: Department of Research, Carolinas HealthCare System , Charlotte, NC, USA.
authors.forename: Yong-Yook
authors.initials: YY
authors.lastname: Lee
authors.forename: Kimberly Q
authors.initials: KQ
authors.lastname: McKinney
authors.forename: Sriparna
authors.initials: S
authors.lastname: Ghosh
authors.forename: David A
authors.initials: DA
authors.lastname: Iannitti
authors.forename: John B
authors.initials: JB
authors.lastname: Martinie
authors.forename: F Ryan
authors.initials: FR
authors.lastname: Caballes
authors.forename: Mark W
authors.initials: MW
authors.lastname: Russo
authors.forename: William A
authors.initials: WA
authors.lastname: Ahrens
authors.forename: Deborah H
authors.initials: DH
authors.lastname: Lundgren
authors.forename: David K
authors.initials: DK
authors.lastname: Han
authors.forename: Herbert L
authors.initials: HL
authors.lastname: Bonkovsky
authors.forename: Sun-Il
authors.initials: SI
authors.lastname: Hwang
mesh_terms: D000368:Aged; D014408:Biomarkers, Tumor / Q000378:metabolism*; D015153:Blotting, Western; D006528:Carcinoma, Hepatocellular / Q000737:chemistry* / Q000473:pathology; D002457:Cell Extracts / Q000737:chemistry*; D002458:Cell Fractionation; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000737:chemistry* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D059748:Proteolysis; D020543:Proteome / Q000737:chemistry*; D053719:Tandem Mass Spectrometry
chemical_list: D014408:Biomarkers, Tumor; D002457:Cell Extracts; D020543:Proteome